Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00446966 · ClinicalTrials.gov registry record · Phase 4
Fish Oil for Reduction of Atrial Fibrillation After Cardiac Surgery
A Phase 4 study of Atrial Fibrillation, sponsored by Chirag Sandesara.
- Completed
- Registry status
- Phase 4
- Development phase
- 260
- Enrollment target
- 1
- Study location
NCT00446966 is a Phase 4 study of Atrial Fibrillation that has completed, run by Chirag Sandesara. The registered enrollment target is 260 participants, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00446966, a Phase 4 study of Atrial Fibrillation, has completed, sponsored by Chirag Sandesara.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 260 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to determine if omega-3 polyunsaturated fatty acids reduce atrial fibrillation and other outcomes after cardiac surgery. In this placebo-controlled trial, patients undergoing elective coronary artery bypass graft surgery with or without valve repair will be treated with omega-3 polyunsaturated fatty acids perioperatively. The following hypotheses will be tested: 1. omega-3 polyunsaturated fatty acids reduces the incidence of atrial fibrillation (AF) after cardiac surgery, 2. omega-3 polyunsaturated fatty acids, administered in the perioperative period for cardiac surgery, decreases postoperative complication rates, and 3. omega-3 polyunsaturated fatty acids decrease intensive care unit and hospital length-of-stay.
Conditions Studied
Interventions
- DRUG Omega Three Polyunsaturated fatty acids
Study Locations (1)
Iowa
- University of Iowa Hospitals and Clinics - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2007-02 |
| Est. Completion | 2010-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00446966
The ClinicalTrials.gov registry entry for NCT00446966 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,996-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (91% lower). The listed sponsor is Chirag Sandesara, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Omega Three Polyunsaturated fatty acids is the first listed.
NCT00446966 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.
Frequently Asked Questions
What is clinical trial NCT00446966 about?
NCT00446966 is a clinical study titled "Fish Oil for Reduction of Atrial Fibrillation After Cardiac Surgery". The primary objective of this study is to determine if omega-3 polyunsaturated fatty acids reduce atrial fibrillation and other outcomes after cardiac surgery. In this placebo-controlled trial, patients undergoing elective coronary artery bypass graft surgery with or without valve repair will be tre...
What is the current status of trial NCT00446966?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 260 participants. The study started on 2007-02. Estimated completion is 2010-01.
What conditions does trial NCT00446966 study?
This clinical trial studies the following conditions: Atrial Fibrillation.
What interventions are being tested in trial NCT00446966?
The interventions under investigation include: Omega Three Polyunsaturated fatty acids (DRUG).
Who is sponsoring clinical trial NCT00446966?
This trial is sponsored by Chirag Sandesara, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00446966 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure
RECRUITING · Phase 4
-
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
RECRUITING · Phase 4
-
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
RECRUITING · Phase 4
-
Ondansetron for the Management of Atrial Fibrillation
RECRUITING · Phase 4
-
EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
ACTIVE NOT RECRUITING · Phase 4
-
Therapeutic Initial Heparin Dosing for Patients With Clots or Certain Heart Conditions Admitted to the Hospital
ACTIVE NOT RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.